HIDRADENITIS SUPPURATIVA

This study looks at the long-term safety of the drug bimekizumab for people with moderate to severe hidradenitis suppurativa (HS), a painful skin condition. About 658 adults who completed earlier studies will receive open-label bimekizumab. The main goal is to track side effects …

This study tests five different investigational drugs in 248 adults with moderate to severe hidradenitis suppurativa, a chronic skin condition causing painful boils. The main goal is to see if these drugs reduce abscesses and inflamed bumps by at least half without increasing dra…

This study looks at how well secukinumab works over the long term for people with moderate to severe hidradenitis suppurativa, a painful skin condition. About 700 adults who completed a previous year-long study will either continue or pause treatment to see if the response lasts.…

This study looks at the long-term safety and how well the drug sonelokimab works for people with moderate to severe hidradenitis suppurativa (HS), a painful skin condition. It includes about 835 adults and teens who already completed an earlier sonelokimab study. Participants wil…

This study tests a drug called sonelokimab in 35 teens aged 12 to 17 with moderate to severe hidradenitis suppurativa (HS), a painful skin condition. The main goals are to see how the drug moves through the body and if it is safe. Researchers will also check if it helps reduce sk…

This study tests a new drug called eltrekibart in 352 adults with moderate to severe hidradenitis suppurativa (HS), a painful skin condition that causes boils and abscesses. The goal is to find the best dose to reduce symptoms like skin pain and flare-ups. Participants will recei…

This study follows 434 adults with moderate to severe hidradenitis suppurativa (HS) who are taking secukinumab, a medication that helps control the disease. Researchers will observe how patients adjust their dosing (increase or decrease) over two years and what factors influence …

This study tests an experimental drug called lutikizumab for adults with moderate-to-severe hidradenitis suppurativa (HS), a chronic skin condition causing painful lumps and scars. The main part of the study includes about 160 people who have already tried and failed anti-TNF the…

This study tests an experimental drug called brensocatib in 214 adults with moderate to severe hidradenitis suppurativa (HS), a painful skin condition that causes boils and abscesses. Participants receive either the drug or a placebo for 16 weeks to see if it reduces inflammatory…

This study tracks 107 adults with moderate to severe hidradenitis suppurativa (HS) who are taking secukinumab as part of their normal care. Researchers want to see how well the drug reduces skin abscesses and tunnels in everyday practice. The goal is to understand real-world effe…

This early-stage study tests a single dose of an experimental drug called SBT777101 in 24 adults with moderate-to-severe hidradenitis suppurativa (painful skin boils). The main goal is to check safety and side effects, while also seeing how the drug works in the body. Researchers…

This study tests a new drug called tulisokibart in 147 people with moderate to severe hidradenitis suppurativa, a painful skin condition. Participants receive either the drug or a placebo to see if it reduces abscesses and inflammation by at least half after 16 weeks. The goal is…

This study tests whether anifrolumab, a drug that blocks certain immune processes, can help people with hidradenitis suppurativa (HS) — a painful skin condition causing boils and tunnels. About 15 adults with moderate-to-severe HS will receive the drug intravenously over 24 weeks…

This study follows 192 adults with hidradenitis suppurativa (HS) for 12 months after they start taking secukinumab. Researchers ask patients to rate their pain, oozing, and bad smell on a 0-10 scale to see if symptoms improve. The goal is to understand the real-world impact of th…

This study tests whether a 1726nm laser (AviClear) can safely reduce painful bumps and abscesses in people with hidradenitis suppurativa (HS). Eight adults with mild-to-moderate HS will receive laser treatment on affected areas like armpits or groin. The main goal is to see if at…

This study aimed to see if gentian violet, a purple dye used as an antiseptic, could help people with hidradenitis suppurativa (HS), a painful skin condition. Participants would have rated changes in redness, drainage, and pain after one treatment. However, the study was withdraw…

This study planned to test a fractional ablative erbium laser on armpit scars caused by hidradenitis suppurativa, a chronic skin condition. It was designed for adults with mild to no active disease. However, the study was withdrawn before any participants enrolled, so no results …

This study aimed to see if Botulinum Toxin-A (Botox) could help people with hidradenitis suppurativa, a painful skin condition. It planned to enroll adults with active armpit lesions of similar severity on both sides. However, the study was withdrawn before any participants were …

This study looks at whether a specially designed exercise program can improve strength, endurance, and quality of life for adults with hidradenitis suppurativa (HS), a chronic skin condition that causes painful boils. Researchers will measure changes in physical function and dail…

This study looks at how satisfied adults with moderate to severe hidradenitis suppurativa (HS) are with their treatment and how their quality of life changes after starting secukinumab. About 48 participants in the United Arab Emirates will fill out questionnaires over a short pe…

This study is creating a large registry of up to 15,000 adults and children with inflammatory skin conditions like eczema, psoriasis, and vitiligo. Researchers will follow participants over time to see how treatments work in everyday medical practice and track any side effects. T…